200,000+ products from a single source!

sales@angenechem.com

Home > Quinoline > 4945-26-0

4945-26-0

4945-26-0 | 2-Styrylquinoline

CAS No: 4945-26-0 Catalog No: AG00E0FM MDL No:

Product Description

Catalog Number:
AG00E0FM
Chemical Name:
2-Styrylquinoline
CAS Number:
4945-26-0
IUPAC Name:
2-[(E)-2-phenylethenyl]quinoline
InChI:
InChI=1S/C17H13N/c1-2-6-14(7-3-1)10-12-16-13-11-15-8-4-5-9-17(15)18-16/h1-13H/b12-10+
InChI Key:
RLGKSXCGHMXELQ-ZRDIBKRKSA-N

Properties

Complexity:
277  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
231.105g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
231.298g/mol
Monoisotopic Mass:
231.105g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
12.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.5  

Literature

Title Journal
(E)-5-styryl-1H-indole and (E)-6-styrylquinoline derivatives serve as probes for β-amyloid plaques. Molecules (Basel, Switzerland) 20120410
Simplified molecular input-line entry system and International Chemical Identifier in the QSAR analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors. Chemical biology & drug design 20110501
Evaluation of the trypanocidal, cytotoxic and genotoxic activity of styrylquinoline analogs. Journal of chemotherapy (Florence, Italy) 20100601
Chemistry and structure-activity relationship of the styrylquinoline-type HIV integrase inhibitors. Molecules (Basel, Switzerland) 20100427
Solvent effects on the spectroscopic properties of styrylquinolinium dyes series. Journal of fluorescence 20100101
Synthesis and antiproliferative evaluations of certain 2-phenylvinylquinoline (2-styrylquinoline) and 2-furanylvinylquinoline derivatives. Bioorganic & medicinal chemistry 20100101
Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors. European journal of medicinal chemistry 20080101
Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines. Bioorganic & medicinal chemistry letters 20071115
Crystal and electronic structures of magnesium(II), copper(II), and mixed magnesium(II)-copper(II) complexes of the quinoline half of styrylquinoline-type HIV-1 integrase inhibitors. The journal of physical chemistry. B 20070531
Comparative molecular surface analysis (CoMSA) for virtual combinatorial library screening of styrylquinoline HIV-1 blocking agents. Combinatorial chemistry & high throughput screening 20061201
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Experimental/theoretical electrostatic properties of a styrylquinoline-type HIV-1 integrase inhibitor and its progenitors. The journal of physical chemistry. B 20060112
Prediction of genotoxicity of chemical compounds by statistical learning methods. Chemical research in toxicology 20050601
Analogues of the styrylquinoline and styrylquinazoline HIV-1 integrase inhibitors: design and synthetic problems. Acta poloniae pharmaceutica 20041201
Nuclear import of HIV-1 integrase is inhibited in vitro by styrylquinoline derivatives. Molecular pharmacology 20041001
Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies. Acta pharmacologica Sinica 20040701
Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents. Journal of virology 20040601
Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro. Molecular pharmacology 20040101
Synthesis of styrylbenzofuran derivatives as styrylquinoline analogues for HIV-1 integrase inhibitor. Farmaco (Societa chimica italiana : 1989) 20031201

Related Products

© 2019 Angene International Limited. All rights Reserved.